Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study

PURPOSE: Proton pump inhibitor (PPI) therapy causes hypergastrinemia, which could promote the development and progression of pancreatic cancer. Accordingly, this study aimed to investigate the association between PPI exposure and the risk of pancreatic cancer. METHODS: We conducted a twelve-year lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, In Cheol, Chang, Jooyoung, Park, Sang Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135510/
https://www.ncbi.nlm.nih.gov/pubmed/30208110
http://dx.doi.org/10.1371/journal.pone.0203918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135510/
https://www.ncbi.nlm.nih.gov/pubmed/30208110
http://dx.doi.org/10.1371/journal.pone.0203918

Ejemplares similares